Skip to main content
. 2017 Jun 13;34(1):64–73. doi: 10.1007/s12264-017-0149-7

Fig. 6.

Fig. 6

NF-κB inhibition down-regulated CX3CR1 expression, and CX3CR1 blockade down-regulated the pNF-κB level in the dorsal horn. A, B PDTC down-regulated the CX3CR1 level on days 1 and 3 after TSS. C PDTC attenuated TSS-induced CX3CL1 expression on day 1. DF CX3CR1 antibody inhibited the TSS-induced phosphorylation of NF-κB. *P < 0.05, **P < 0.01.